IRIDEX

Mountain View, United States Founded: 1989 • Age: 37 yrs Listed
Manufacturer of ophthalmic laser systems and related devices

About IRIDEX

IRIDEX is a company based in Mountain View (United States) founded in 1989. The company has 93 employees. IRIDEX offers products and services including Cyclo G6, OcuLight IQ 532, and MicroPulse P3.

  • Headquarter Mountain View, United States
  • Employees 93
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website iridex.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Iridex Corporation
Key Metrics
  • Annual Revenue
    $52.67 M (USD)
    8.23
    as on Dec 31, 2025
  • Net Profit
    -$4.44 M (USD)
    50.2
    as on Dec 31, 2025
  • EBITDA
    -$1.02 M (USD)
    85.11
    as on Dec 31, 2025
  • Latest Funding Round
    $10M (USD), Post-IPO

    Mar 2025

  • Employee Count
    93

Products & Services of IRIDEX

IRIDEX offers a comprehensive portfolio of products and services, including Cyclo G6, OcuLight IQ 532, and MicroPulse P3.

Cyclo G6
Glaucoma Device

Laser for transscleral cyclophotocoagulation in glaucoma management

OcuLight IQ 532
Laser Device

System for retinal treatments including diabetic macular edema

MicroPulse P3
Glaucoma Device

Device for microsecond pulse laser therapy in eye care

Apps and channels of IRIDEX

its YouTube channel Iridex Glaucoma has 2.77K subscribers and 30 videos.

Iridex Glaucoma
YouTube 2.77K subscribers 30 videos Science & Technology
Open channel

Videos from IRIDEX

The most watched videos on IRIDEX's YouTube channel, Iridex Glaucoma (2.77K subscribers). Click a video to play it here.

MicroPulse TLT Consensus: Panel Discussion (Part 1)
2.7K views
Iridex Sweep Management Software Training Video
2.4K views
MicroPulse Laser for Diabetic Macular Edema and Retinal Vein Occlusion: Best Practices
2K views
Terapia Láser Transescleral MicroPulse y Terapia Láser Subumbral (PASCAL) para el Glaucoma
1.8K views

More on Iridex Glaucoma.

Funding Insights of IRIDEX

  • Total Rounds 1
  • Last Round Post-IPO — $10M
  • First Round $10M

    (Mar 2025)

All 1 funding rounds of IRIDEX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2025$10MPost-IPO––
–

People of IRIDEX

4 people are tracked at IRIDEX (4 in leadership); the tracked headcount is 93.

NameRoleGroup
David I. Bruce
President and CEOLeadership
George R. Marcellino
Vice President Clinical AffairsLeadership
Romeo R. Dizon
Vice President of FinanceLeadership
Craig Warner
VP Of SalesLeadership
Premium access

Complete people profiles for IRIDEX

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of IRIDEX

IRIDEX is a publicly listed company on the NASDAQ with ticker symbol IRIX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date15 Feb 1996
  • Listed onNASDAQ: IRIX
  • Listed entityIRIDEX Corporation
  • Exchange sectorHealth technology
  • ISINUS4626841013
  • Share price$0.89 (-0.89% on the day) · 2026-10-09
  • Market capitalisation$15.6M
  • EPS (diluted, trailing year)$-0.21
  • Volume (last session)203,194

Financials of IRIDEX

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$52.7M-$4.4M-$1.0M
2024$48.7M-$8.9M-$6.9M
2023$51.9M-$9.6M-$8.0M
2022$57.0M-$7.5M-$6.2M
2021$53.9M-$5.2M-$6.7M
Premium access

Detailed financial statements for IRIDEX

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of IRIDEX

3 dated milestones of IRIDEX across 36 years, from founding to its latest funding, stage changes and deals.

  1. Founded IRIDEX is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $10.0M.

Web traffic of IRIDEX

The website of IRIDEX (iridex.com) receives about 9.7K visits a month.

  • Monthly visits
    9.7K

    ▲ 27.7% vs previous month

Similar websites

Websites whose visitors overlap most with IRIDEX. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
topconhealthcare.jp
topconhealthcare.jp
100%
–#2,046,560–
agilitihealth.com
100%
61.9K#310,777View details
resonetics.com
100%
17.4K#1,520,917View details
revmedconnect.com
revmedconnect.com
100%
–#771,336–
inmodemd.com
100%
48.1K#709,913View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 7 similar websites and full traffic analytics for IRIDEX

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Iridex

Premium access

Complete news archive for IRIDEX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to IRIDEX

10 companies that operate in the same segment as IRIDEX (Diversified Medical Devices), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medical equipment for treating over 30 chronic diseases is developed.
1949Minneapolis, Minnesota, United States–USD 36.36 B95,000
Wide range of medical devices
1979Marlborough, Massachusetts, United States–USD 20.07 B53,000
Healthcare solutions are provided by Johnson & Johnson globally.
1886New Brunswick, New Jersey, United States–USD 94.18 B139,800
Diagnostic and surgical products for women's healthcare are provided.
1985Marlborough, Massachusetts, United States–USD 4.1 B7,060
Developer of drug candidates for the treatment of rare CNS disorders
1971Boston, Massachusetts, United StatesUSD 105.8 M–487
Surgical instruments are manufactured for multiple therapeutic areas.
1987Utica, New York, United States–USD 1.37 B3,900
A wide range of medical devices is developed by HOYA.
1941Tokyo, Tokyo, Japan–USD 5.94 B37,910
Medical devices for cardiac and neuromodulation therapies are manufactured globally.
1976Saint Paul, Minnesota, United States–––
Complex healthcare challenges are addressed through technology solutions by Commure.
2016San Francisco, California, United StatesUSD 823.3 M–316
Provider of medical devices for emergency medicine and various health conditions
1943Wayne, United States–USD 1.99 B14,100
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about IRIDEX

IRIDEX was founded in 1989 and raised its 1st funding round 36 years after it was founded.

IRIDEX is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.

IRIDEX has 93 employees.

Annual revenue of IRIDEX is $52.67M as on Dec 31, 2025.

Manufacturer of ophthalmic laser systems and related devices. It develops, manufactures, and markets laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. The company offers solutions for retinal and glaucoma treatments, including MicroPulse laser technology. Products encompass lasers, probes, consumables, and glaucoma devices, supporting both office-based and hospital settings. The company provides clinical and technical support.

IRIDEX offers Cyclo G6, OcuLight IQ 532, and MicroPulse P3.

Yes, IRIDEX is publicly traded on NASDAQ under the ticker symbol IRIX.

IRIDEX operates through Iridex Corporation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available